Prevention of ischemia-induced reentrant ventricular arrhythmias by a peptide that enhances gap junctional conductance

Journal of Cardiovascular Electrophysiology

Volumn 14, Issue 5, 2003, Pages 521-523

  Pogwizd, Steven M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC PEPTIDE; CONNEXIN 43; ROTIGAPTIDE; UNCLASSIFIED DRUG;

CELL ADHESION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; GAP JUNCTION; HEART CONDUCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE POTENTIAL; HUMAN; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REENTRY ARRHYTHMIA; SUDDEN DEATH;

ANIMALS; GAP JUNCTIONS; HEART CONDUCTION SYSTEM; HUMANS; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; OLIGOPEPTIDES; TACHYCARDIA, ATRIOVENTRICULAR NODAL REENTRY;

EID: 0037904763     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2003.03137.x     Document Type: Note

References (34)

1. Fujimoto T, Peter R, Hamamoto H, Mandel WJ: Electrophysiological observations during the spontaneous initiation of ischemia induced ventricular fibrillation. Am Heart J 1983;105:189-197.
2. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-412.
3. Pogwizd SM, Corr PB: Reentrant and nonreentrant mechanisms contribute to arrhythmogenesis during early myocardial ischemia: Results using three-dimensional mapping. Circ Res 1987;61:352-371.
4. Pogwizd SM, Corr PB: Mechanisms underlying the development of ventricular fibrillation during early myocardial ischemia. Circ Res 1990;66:672-695.
5. Wit AL, Rosen MR: Afterdepolarizations and triggered activity: Distinction from automaticity as an arrhythmogenic mechanism. In Fozzard HF, Haber E, Jennings RB, Katz AM, Morgan HE, eds: The Heart and Cardiovascular System: Scientific Foundations. Second Edition. New York: Raven Press, 1993, pp. 2113-2163.
6. Zipes DP, Wellens HJJ: Sudden cardiac death. Circulation 1998;98:2334-2351.
7. Kleber AG, Riegger CB, Janse MJ: Electrical uncoupling and increase of extracellular resistance after induction of ischemia in isolated, arterially perfused rabbit papillary muscle. Circ Res 1987;61:271-279.
8. Beardslee MA, Lerner DL, Tadros PN, Laing JG, Beyer EC, Yamada KA, Kleber AG, Schuessler RB, Saffitz JE: Dephosphorylation and intracellular redistribution of ventricular connexin43 during electrical uncoupling induced by ischemia. Circ Res 2000;87:656-662.
9. Elof BC, Lerner DL, Yamada KA, Schuessler RB, Saffitz JE, Rosenbaum DS: High resolution optical mapping reveals conduction slowing in connexin43 deficient mice. Cardiovasc Res 2001;51:681-690.
10. Lerner DL, Yamada KA, Schuessler RB, Saffitz JE: Accelerated onset and increased incidence of ventricular arrhythmias induced by ischemia in Cx43-deficient mice. Circulation 2000;101:547-552.
11. Kumar NM, Gilula NB: Molecular biology and genetics of gap junction channels. Semin Cell Biol 1992;3:3-16.
12. van Kempen MJ, Fromaget C, Gross D, Moorman AF, Lamers WH: Spatial distribution of connexin43, the major cardiac gap junction protein, in developing and adult rat heart. Circ Res 1991;68:1638-1651.
13. Lau AF, Hatch-Pigott V, Crow DS: Evidence that heart connexin43 is a phosphoproteins. J Mol Cell Cardiol 1991;23:659-663.
14. Kanno S, Saffitz JE: The role of myocardial gap junctions in electrical conduction and arrhythmogenesis. Cardiovasc Pathol 2001;10:169-177.
15. i. J Cardiovasc Electrophysiol 1997;8:939-951.
16. Lampe PD, Lau AF: Regulation of gap junctions by phosphorylation of connexins. Arch Biochem Biophys 2000;384:205-215.
17. Jeyaraman M, Tanguy S, Fandrich RR, Lukas A, Kardami E: Ischemia-induced dephosphorylation of cardiomyocyte connexin-43 is reduced by okadaic acid and calyculin A but not fostriecin. Mol Cell Biochem 2003;242:129-134.
18. Duthe F, Plaisance I, Sarrouilhe D, Herve JC: Endogenous protein phosphatase 1 runs down gap junctional communication of rat ventricular myocytes. Am J Physiol 2001;281:C1648-C1656.
19. Dhein S: Peptides acting at gap junctions. Peptides 2002:23:1701-1709.
20. De Mello W, Altieri P: The role of the renin-angiotensin system in the control of cell communication in the heart: Effects of enalapril and angiotensin II. J Cardiovasc Pharmacol 1992;20:643-651.
21. Berthoud VM, Beyer EC, Seul KH: Peptide inhibitors of intercellular communication. Am J Physiol 2000;279:L619-L622.
22. Calero G, Kanemitsu M, Taffet SM, Lau AF, Delmar M: A 17mer peptide interferes with acidification-induced uncoupling of connexin43. Circ Res 1998;82:929-935.
23. Dhein S: Gap junction channels in the cardiovascular system: Pharmacological and physiological modulation. TIPS 1998;19:229-241.
24. Aonuma S, Kohama Y, Akai K, Komiyama Y, Nakajima S, Wakabayashi M, Makino T: Studies on Heart. XIX. Isolation of an atrial peptide that improves the rhythmicity of cultured myocardial cell clusters. Chem Pharm Bull 1980;28:3332-3339.
25. Aonuma S, Kohama Y, Makino T, Hattori K: Studies on Heart. XXII. Inhibitory effect of an atrial peptide (AAP) on several drug-induced arrhythmias in vivo. Yakugaku Zasshi 1983;103:662-666.
26. Argentieri T, Cantor E, Wiggins JR: Antiarrhythmic peptide has no direct cardiac action. Experientia 1989;45:737-738.
27. Dhein S, Manicone N, Muller A, Gerwin R, Ziskoven U, Irankhanhi A, Minke C, Klaus W: A new synthetic antiarrhythmic peptide reduces dispersion of epicardial activation recovery interval and diminishes alterations of epicardial activation patterns induced by regional ischemia. A mapping study. Naunyn-Schmiedebergs Arch Pharmacol 1994;350:174-184.
28. Muller A, Gottwald M, Tudyka T, Linke W, Klaus W, Dhein S: Increase in gap junctional conductance by an antiarrhythmic peptide. Eur J Pharmacol 1997;327:65-72.
29. Weng S, Lauven M, Schaefer T, Polontchouk L, Grovers R, Dhein S: Pharmacological modifications of gap junction coupling by an antiarrhythmic peptide via protein kinase C activation. FASEB J 2002;16:1114-1116.
30. Xing D, Kjølbye AL, Nielsen MS, Petersen JS, Harlow KW, Holstein-Rathlou N-H, Martins JB: ZP123 increases gap junctional conductance and prevents reentrant ventricular tachycardia during myocardial ischemia in open chest dogs. J Cardiovasc Electrophysiol 2003;14:510-520.
31. Elof BC, Gilat E, Rosenbaum DS: Cardiac gap junction modification by ZP123 inhibits acidosis-induced conduction slowing. Circulation 2002;106:II-87-I-88.
32. Arnar DO, Bullinga JR, Martins JB: The role of the Purkinje system in spontaneous ventricular tachycardia during acute ischemia in a canine model. Circulation 1997;96:2421-2429.
33. Wilders R, Wagner MB, Golod DA, Kumar R, Wang YG, Goolsby WN, Joyner RW, Jongsma HJ: Effects of anisotropy on the development of cardiac arrhythmias with focal activity. Pflugers Arch 2000;441:301-312.
34. Rohr S, Kucera JP, Fast VG, Kleber AG: Paradoxical improvement of impulse conduction in cardiac tissue by partial cellular uncoupling. Science 1997;275:841-844.